What is the current Thrombin Market size?

The Thrombin Market is projected to register a CAGR of 4.30% during the forecast period (2024-2029) Read More

Who are the key players in Thrombin Market?

Pfizer Inc., Johnson & Johnson, Baxter, Shanghai RAAS blood products co., Ltd and General Electric Company (GE Healthcare) are the major companies operating in the Thrombin Market. Read More

Which is the fastest growing region in Thrombin Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Thrombin Market?

In 2024, the North America accounts for the largest market share in Thrombin Market. Read More

What years does this Thrombin Market cover?

The report covers the Thrombin Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Thrombin Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Thrombin Market - Share & Size

Thrombin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Thrombin Market is Segmented by Product (Bovine Thrombin, Human Thrombin, and Recombinant Thrombin), Dosage Form (Powder Form and Solution Form), End-User (Hospitals, Diagnostics Centers & Clinics, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Thrombin Industry Overview

The market for thrombin is moderately competitive and is currently dominated by several major players. Some of the companies that are leading the market include Pfizer Inc., Johnson & Johnson Services Inc., Mallinckrodt Pharmaceuticals, Shanghai RAAS Blood Products Co., Ltd, Japan Blood Products Organization, Mochida Pharmaceutical Co., Ltd., Octapharma, Bayer, Baxter, and General Electric Company (GE Healthcare).